Ascent Group LLC acquired a new position in shares of Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 55,268 shares of the company's stock, valued at approximately $569,000.
Several other institutional investors have also added to or reduced their stakes in the stock. Millennium Management LLC raised its holdings in Haleon by 697.2% during the 1st quarter. Millennium Management LLC now owns 4,216,504 shares of the company's stock worth $43,388,000 after purchasing an additional 3,687,613 shares during the last quarter. Hancock Whitney Corp bought a new stake in shares of Haleon in the 1st quarter valued at $120,000. Banque Transatlantique SA acquired a new stake in shares of Haleon during the first quarter worth $27,000. Bain Capital Public Equity Management II LLC raised its stake in Haleon by 8.8% during the first quarter. Bain Capital Public Equity Management II LLC now owns 3,093,270 shares of the company's stock worth $31,830,000 after buying an additional 249,260 shares during the last quarter. Finally, AQR Capital Management LLC lifted its holdings in Haleon by 22.5% in the first quarter. AQR Capital Management LLC now owns 96,323 shares of the company's stock valued at $991,000 after buying an additional 17,720 shares during the period. 6.67% of the stock is currently owned by institutional investors.
Haleon Stock Down 0.7%
Haleon stock traded down $0.07 during midday trading on Friday, reaching $9.81. The stock had a trading volume of 7,825,877 shares, compared to its average volume of 7,793,643. The company has a fifty day moving average price of $9.73 and a two-hundred day moving average price of $10.20. Haleon PLC Sponsored ADR has a 12 month low of $8.86 and a 12 month high of $11.42. The company has a current ratio of 0.87, a quick ratio of 0.63 and a debt-to-equity ratio of 0.48. The company has a market capitalization of $43.91 billion, a P/E ratio of 25.14, a PEG ratio of 2.91 and a beta of 0.24.
Haleon Increases Dividend
The company also recently disclosed a semi-annual dividend, which will be paid on Thursday, September 18th. Stockholders of record on Friday, August 15th will be issued a dividend of $0.0555 per share. This is a positive change from Haleon's previous semi-annual dividend of $0.05. This represents a dividend yield of 190.0%. The ex-dividend date is Friday, August 15th. Haleon's dividend payout ratio is presently 28.21%.
Analyst Upgrades and Downgrades
HLN has been the topic of a number of research analyst reports. BNP Paribas Exane raised shares of Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 price target on the stock in a research report on Tuesday, May 27th. Wall Street Zen downgraded Haleon from a "buy" rating to a "hold" rating in a research note on Saturday, July 12th. The Goldman Sachs Group raised Haleon from a "neutral" rating to a "buy" rating in a research note on Wednesday. Finally, BNP Paribas upgraded Haleon to a "strong-buy" rating in a report on Tuesday, May 27th. Two analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, Haleon has a consensus rating of "Moderate Buy" and a consensus target price of $12.33.
Read Our Latest Research Report on Haleon
About Haleon
(
Free Report)
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
Featured Articles
Before you consider Haleon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Haleon wasn't on the list.
While Haleon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
